We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cardiac Bypass Surgery Made Easier

By HospiMedica staff writers
Posted on 16 Apr 2007
A new anastomosis system facilitates blood vessel connection during less invasive coronary artery bypass graft (CABG) procedures.

The C-Port Flex A anastomosis system has been designed to enable automated, reliable, and reproducible connections of blood vessels during CABG surgery. More...
The system is effective in creating compliant anastomoses (connections of blood vessels) in vessels as small as 1 mm in internal diameter and can be used in either on- or off-pump CABG procedures. The system has a flexible, rather than rigid, shaft, designed to allow the working end of the device to be inserted through a 12-mm diameter port to access the chest cavity and heart. The device is then loaded with the bypass graft vessel (inside or outside the chest cavity) and deployed to create the anastomosis to the coronary artery. The system is designed to enable completion of robotically assisted (including endoscopic) CABG surgery through four or five relatively small incisions between the ribs.

By replacing hand-sewn sutures with easy-to-use automated systems, the system provides cardiovascular surgeons with a rapid and accurate way to perform anastomoses, often considered the most critical aspect of the CABG procedure. The C-Port Flex A anastomosis system was developed by Cardica (Redwood City, CA USA) and has been approved by the U.S. Food and Drug Administration (FDA). The new system is a variation of Cardica's C-Port xA distal anastomosis system product line.

"We are excited about the clearance of the C-Port Flex A system because it gives surgeons improved maneuverability and brings us several steps closer to the possibility of performing truly minimally invasive cardiac surgery,” said Valavanur Subramanian, M.D., director of surgery for Lenox Hill Heart and Vascular Institute (New York, NY, USA). "This device enables surgeons to consistently and reliably create automated anastomoses in areas of the heart that are difficult to reach, and particularly difficult to hand-suture, especially during beating heart procedures.”


Related Links:
Cardica

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.